

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.25391904 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.78663289 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.67038242 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.56771825 |
| 5 | glutamate secretion (GO:0014047) | 5.54260752 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.50538808 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.43249036 |
| 8 | vocalization behavior (GO:0071625) | 5.40009857 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.38422291 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.19476721 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.10184498 |
| 12 | neuronal action potential propagation (GO:0019227) | 5.05589811 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93622857 |
| 14 | L-amino acid import (GO:0043092) | 4.68969965 |
| 15 | protein localization to synapse (GO:0035418) | 4.63437504 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.62188661 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.56238241 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.55238264 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.44593173 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.39911892 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.39874805 |
| 22 | amino acid import (GO:0043090) | 4.35447894 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.34197386 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.26206988 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.25122363 |
| 26 | exploration behavior (GO:0035640) | 4.25024776 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.22021848 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.17747871 |
| 29 | long-term memory (GO:0007616) | 3.95161242 |
| 30 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.94330233 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.94279604 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.90284651 |
| 33 | proline transport (GO:0015824) | 3.86060250 |
| 34 | neuronal ion channel clustering (GO:0045161) | 3.85565501 |
| 35 | positive regulation of membrane potential (GO:0045838) | 3.83943023 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.80001065 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.78348173 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.75028298 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.74218479 |
| 40 | long-term synaptic potentiation (GO:0060291) | 3.72847427 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 3.71946865 |
| 42 | potassium ion homeostasis (GO:0055075) | 3.70983205 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.70293772 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.67857775 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66851611 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.64898175 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.62298362 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.59443849 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.57556222 |
| 50 | regulation of neurotransmitter secretion (GO:0046928) | 3.56161880 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56106127 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.53188138 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.52531526 |
| 54 | neurotransmitter transport (GO:0006836) | 3.51974278 |
| 55 | positive regulation of dendritic spine development (GO:0060999) | 3.46636984 |
| 56 | potassium ion import (GO:0010107) | 3.44921010 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.39491115 |
| 58 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.38668877 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38023875 |
| 60 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.37724101 |
| 61 | cell communication by electrical coupling (GO:0010644) | 3.36629656 |
| 62 | regulation of vesicle fusion (GO:0031338) | 3.34527154 |
| 63 | serotonin metabolic process (GO:0042428) | 3.33887243 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.33673151 |
| 65 | synaptic vesicle endocytosis (GO:0048488) | 3.32874710 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.32468351 |
| 67 | regulation of neurotransmitter transport (GO:0051588) | 3.31491365 |
| 68 | central nervous system myelination (GO:0022010) | 3.30187283 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.30187283 |
| 70 | response to histamine (GO:0034776) | 3.29743111 |
| 71 | neuromuscular synaptic transmission (GO:0007274) | 3.28334905 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 3.27992464 |
| 73 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.27772965 |
| 74 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.27662628 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.27649051 |
| 76 | membrane depolarization during action potential (GO:0086010) | 3.27014516 |
| 77 | presynaptic membrane assembly (GO:0097105) | 3.26601096 |
| 78 | cerebellar granule cell differentiation (GO:0021707) | 3.25606956 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25408735 |
| 80 | regulation of neurotransmitter levels (GO:0001505) | 3.23783299 |
| 81 | membrane depolarization (GO:0051899) | 3.23535681 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.22044877 |
| 83 | behavioral fear response (GO:0001662) | 3.21626420 |
| 84 | behavioral defense response (GO:0002209) | 3.21626420 |
| 85 | detection of calcium ion (GO:0005513) | 3.21434229 |
| 86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.20244709 |
| 87 | transmission of nerve impulse (GO:0019226) | 3.19658827 |
| 88 | auditory behavior (GO:0031223) | 3.17358491 |
| 89 | startle response (GO:0001964) | 3.16511448 |
| 90 | neuron recognition (GO:0008038) | 3.14008566 |
| 91 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.13860497 |
| 92 | fear response (GO:0042596) | 3.13687979 |
| 93 | sodium ion export (GO:0071436) | 3.13683507 |
| 94 | behavioral response to cocaine (GO:0048148) | 3.12925951 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11786711 |
| 96 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11285959 |
| 97 | vesicle docking involved in exocytosis (GO:0006904) | 3.09079548 |
| 98 | membrane hyperpolarization (GO:0060081) | 3.08588989 |
| 99 | positive regulation of synaptic transmission (GO:0050806) | 3.08346444 |
| 100 | presynaptic membrane organization (GO:0097090) | 3.07297963 |
| 101 | learning (GO:0007612) | 3.06772439 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06506896 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04778400 |
| 104 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04275303 |
| 105 | innervation (GO:0060384) | 3.03525736 |
| 106 | prepulse inhibition (GO:0060134) | 3.02534099 |
| 107 | regulation of synaptic transmission (GO:0050804) | 3.02443778 |
| 108 | primary amino compound metabolic process (GO:1901160) | 3.02031671 |
| 109 | dendritic spine organization (GO:0097061) | 3.00590968 |
| 110 | glycine transport (GO:0015816) | 2.99950287 |
| 111 | * synaptic transmission (GO:0007268) | 2.99823033 |
| 112 | response to auditory stimulus (GO:0010996) | 2.99141880 |
| 113 | social behavior (GO:0035176) | 2.98224613 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 2.98224613 |
| 115 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97329487 |
| 116 | neurotransmitter uptake (GO:0001504) | 2.95974383 |
| 117 | long term synaptic depression (GO:0060292) | 2.95860079 |
| 118 | neuromuscular process (GO:0050905) | 2.95548725 |
| 119 | acidic amino acid transport (GO:0015800) | 2.95123942 |
| 120 | striatum development (GO:0021756) | 2.94505912 |
| 121 | chemosensory behavior (GO:0007635) | 2.94458832 |
| 122 | axonal fasciculation (GO:0007413) | 2.93794600 |
| 123 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93586328 |
| 124 | synapse assembly (GO:0007416) | 2.92699039 |
| 125 | regulation of glutamate secretion (GO:0014048) | 2.91525828 |
| 126 | regulation of dendritic spine development (GO:0060998) | 2.90934206 |
| 127 | establishment of synaptic vesicle localization (GO:0097480) | 2.89975804 |
| 128 | synaptic vesicle transport (GO:0048489) | 2.89975804 |
| 129 | vesicle docking (GO:0048278) | 2.87193734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.82551456 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.57994755 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05916804 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98634332 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97564384 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68284763 |
| 7 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.65802120 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63954640 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63954640 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55438563 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54301115 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45978802 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45007507 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37300982 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36578130 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35345999 |
| 17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35084180 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16777834 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15151469 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14760471 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09050932 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07953799 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94061710 |
| 24 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88535853 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87915183 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87452467 |
| 27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83894307 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77672118 |
| 29 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77431208 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72901862 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70349671 |
| 32 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.70127511 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69483514 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65123620 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63145571 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57383971 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49238701 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44758160 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42587215 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41936355 |
| 41 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39294118 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38453694 |
| 43 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.37932024 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36746028 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36568844 |
| 46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36054734 |
| 47 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34539126 |
| 48 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34307956 |
| 49 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33562982 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32584750 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31511966 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30630554 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29289036 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28313289 |
| 55 | AR_19668381_ChIP-Seq_PC3_Human | 1.25895794 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25788473 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24177565 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21020042 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19210247 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19135786 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18693524 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17416333 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16981105 |
| 64 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16014762 |
| 65 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15855936 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15516615 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15442469 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15082911 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14789245 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14628414 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12365578 |
| 72 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12340553 |
| 73 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12198138 |
| 74 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11178224 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10696201 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10094655 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09194765 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09106397 |
| 79 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09047466 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08861657 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08838205 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06682575 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05630887 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04285624 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04242855 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03690620 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03588150 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03210530 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02658884 |
| 90 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01818088 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00615077 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99840169 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99183702 |
| 94 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98511439 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96963701 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96838992 |
| 97 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96621130 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96141194 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96023824 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95875641 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95859729 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95106202 |
| 103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94755426 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94753068 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94625218 |
| 106 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93655707 |
| 107 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93621773 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93411142 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93303512 |
| 110 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92799812 |
| 111 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92317902 |
| 112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91504913 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91346334 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90325830 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90245788 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90079761 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90025589 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89635301 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89414022 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89414022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.70527351 |
| 2 | MP0003880_abnormal_central_pattern | 4.52130372 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17587636 |
| 4 | MP0004270_analgesia | 3.93541710 |
| 5 | MP0009745_abnormal_behavioral_response | 3.50801156 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.37758633 |
| 7 | MP0002822_catalepsy | 3.35366148 |
| 8 | MP0009046_muscle_twitch | 3.19245912 |
| 9 | MP0002064_seizures | 3.17813227 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.15591487 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.89844767 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.79681798 |
| 13 | MP0002272_abnormal_nervous_system | 2.64968273 |
| 14 | MP0001486_abnormal_startle_reflex | 2.48213130 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.47892553 |
| 16 | MP0002736_abnormal_nociception_after | 2.45120362 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.30543189 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.28540765 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.27754701 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.10975749 |
| 21 | MP0001970_abnormal_pain_threshold | 2.02055602 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.00244499 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.99648084 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.98318315 |
| 25 | MP0003879_abnormal_hair_cell | 1.91851668 |
| 26 | MP0008569_lethality_at_weaning | 1.89334672 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.86374027 |
| 28 | MP0002184_abnormal_innervation | 1.76447007 |
| 29 | MP0004924_abnormal_behavior | 1.75463071 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.75463071 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.72962494 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.71227825 |
| 33 | MP0003787_abnormal_imprinting | 1.69537341 |
| 34 | MP0004858_abnormal_nervous_system | 1.67487857 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.65583893 |
| 36 | MP0003329_amyloid_beta_deposits | 1.61956297 |
| 37 | MP0001984_abnormal_olfaction | 1.53785911 |
| 38 | MP0000955_abnormal_spinal_cord | 1.48839563 |
| 39 | MP0000778_abnormal_nervous_system | 1.44893171 |
| 40 | MP0000920_abnormal_myelination | 1.44854044 |
| 41 | MP0005171_absent_coat_pigmentation | 1.40156743 |
| 42 | MP0001188_hyperpigmentation | 1.36773573 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.35996054 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.34615325 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.31180640 |
| 46 | MP0003633_abnormal_nervous_system | 1.30297049 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.29847937 |
| 48 | MP0003123_paternal_imprinting | 1.25595835 |
| 49 | MP0001348_abnormal_lacrimal_gland | 1.22783528 |
| 50 | MP0001529_abnormal_vocalization | 1.22287411 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.19803252 |
| 52 | MP0004885_abnormal_endolymph | 1.18702483 |
| 53 | MP0001905_abnormal_dopamine_level | 1.18627557 |
| 54 | MP0001346_abnormal_lacrimal_gland | 1.15777712 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.10673423 |
| 56 | MP0003631_nervous_system_phenotype | 1.09469684 |
| 57 | MP0004147_increased_porphyrin_level | 1.07296430 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.07229883 |
| 59 | MP0008872_abnormal_physiological_respon | 1.06233369 |
| 60 | MP0003283_abnormal_digestive_organ | 1.03573241 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.03535369 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.02577072 |
| 63 | MP0002152_abnormal_brain_morphology | 0.98474562 |
| 64 | MP0004142_abnormal_muscle_tone | 0.97758749 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.92703634 |
| 66 | MP0008874_decreased_physiological_sensi | 0.89358209 |
| 67 | MP0005394_taste/olfaction_phenotype | 0.88344697 |
| 68 | MP0005499_abnormal_olfactory_system | 0.88344697 |
| 69 | MP0004043_abnormal_pH_regulation | 0.88046461 |
| 70 | MP0003122_maternal_imprinting | 0.88028835 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.87964252 |
| 72 | MP0002229_neurodegeneration | 0.87877224 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.85613404 |
| 74 | MP0004085_abnormal_heartbeat | 0.85564157 |
| 75 | MP0003075_altered_response_to | 0.79988107 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 0.79066141 |
| 77 | MP0005535_abnormal_body_temperature | 0.78950101 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.78402419 |
| 79 | MP0001963_abnormal_hearing_physiology | 0.77772138 |
| 80 | MP0004742_abnormal_vestibular_system | 0.77302780 |
| 81 | MP0000751_myopathy | 0.75362715 |
| 82 | MP0003632_abnormal_nervous_system | 0.75143139 |
| 83 | MP0001177_atelectasis | 0.74735639 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.69854792 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.69745137 |
| 86 | MP0004484_altered_response_of | 0.66207354 |
| 87 | MP0002653_abnormal_ependyma_morphology | 0.65614431 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.63929921 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.63491022 |
| 90 | MP0002752_abnormal_somatic_nervous | 0.62356419 |
| 91 | MP0003861_abnormal_nervous_system | 0.60648969 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.60139349 |
| 93 | MP0002090_abnormal_vision | 0.59933599 |
| 94 | MP0001664_abnormal_digestion | 0.59557849 |
| 95 | MP0005409_darkened_coat_color | 0.59501271 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.59494258 |
| 97 | MP0003634_abnormal_glial_cell | 0.59276609 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.58354085 |
| 99 | MP0000604_amyloidosis | 0.58042922 |
| 100 | MP0000579_abnormal_nail_morphology | 0.57348549 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.56441991 |
| 102 | MP0001943_abnormal_respiration | 0.56224049 |
| 103 | MP0000026_abnormal_inner_ear | 0.55013789 |
| 104 | MP0004510_myositis | 0.54928618 |
| 105 | MP0003136_yellow_coat_color | 0.53537296 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.53268896 |
| 107 | MP0004233_abnormal_muscle_weight | 0.52840900 |
| 108 | MP0010768_mortality/aging | 0.52193968 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.51854434 |
| 110 | MP0003690_abnormal_glial_cell | 0.51026537 |
| 111 | MP0003045_fibrosis | 0.50079658 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.49732703 |
| 113 | MP0000462_abnormal_digestive_system | 0.49647851 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.49647633 |
| 115 | MP0010769_abnormal_survival | 0.48464873 |
| 116 | MP0003172_abnormal_lysosome_physiology | 0.48399581 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.48269828 |
| 118 | MP0005187_abnormal_penis_morphology | 0.48251841 |
| 119 | MP0003956_abnormal_body_size | 0.48161435 |
| 120 | MP0010770_preweaning_lethality | 0.47789501 |
| 121 | MP0002082_postnatal_lethality | 0.47789501 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.46454216 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.45844936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.47999395 |
| 2 | Myokymia (HP:0002411) | 7.04633181 |
| 3 | Focal seizures (HP:0007359) | 5.98072331 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.33440011 |
| 5 | Visual hallucinations (HP:0002367) | 5.25514450 |
| 6 | Atonic seizures (HP:0010819) | 5.25418841 |
| 7 | Febrile seizures (HP:0002373) | 5.01425036 |
| 8 | Absence seizures (HP:0002121) | 4.33978998 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.23097224 |
| 10 | Action tremor (HP:0002345) | 4.12159370 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.05421081 |
| 12 | Dialeptic seizures (HP:0011146) | 3.95668514 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.84974716 |
| 14 | Broad-based gait (HP:0002136) | 3.83574843 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.67832236 |
| 16 | Hyperventilation (HP:0002883) | 3.52674514 |
| 17 | Poor eye contact (HP:0000817) | 3.52375421 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.38500836 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.21711191 |
| 20 | Amblyopia (HP:0000646) | 3.16903941 |
| 21 | Akinesia (HP:0002304) | 3.16313992 |
| 22 | Impaired social interactions (HP:0000735) | 3.13261835 |
| 23 | Abnormal social behavior (HP:0012433) | 3.13261835 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.07035713 |
| 25 | Truncal ataxia (HP:0002078) | 3.05882065 |
| 26 | Impaired smooth pursuit (HP:0007772) | 3.00504148 |
| 27 | Depression (HP:0000716) | 2.98988928 |
| 28 | Dysmetria (HP:0001310) | 2.98941184 |
| 29 | Ankle clonus (HP:0011448) | 2.96499140 |
| 30 | Anxiety (HP:0000739) | 2.86534283 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.78964629 |
| 32 | Scanning speech (HP:0002168) | 2.76740705 |
| 33 | Papilledema (HP:0001085) | 2.76702994 |
| 34 | Dysmetric saccades (HP:0000641) | 2.76542676 |
| 35 | Postural instability (HP:0002172) | 2.73018884 |
| 36 | Genetic anticipation (HP:0003743) | 2.70054287 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.69132490 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.68732380 |
| 39 | Tetraplegia (HP:0002445) | 2.68660958 |
| 40 | Annular pancreas (HP:0001734) | 2.62091220 |
| 41 | Excessive salivation (HP:0003781) | 2.61105874 |
| 42 | Drooling (HP:0002307) | 2.61105874 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.59775656 |
| 44 | Torticollis (HP:0000473) | 2.54544895 |
| 45 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.54216535 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.53929796 |
| 47 | Stereotypic behavior (HP:0000733) | 2.52328582 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52042481 |
| 49 | Cerebral hypomyelination (HP:0006808) | 2.51087483 |
| 50 | Insidious onset (HP:0003587) | 2.46460629 |
| 51 | Termporal pattern (HP:0011008) | 2.46460629 |
| 52 | Absent speech (HP:0001344) | 2.45292088 |
| 53 | Spastic gait (HP:0002064) | 2.43087719 |
| 54 | Urinary urgency (HP:0000012) | 2.43006629 |
| 55 | Hemiparesis (HP:0001269) | 2.39653901 |
| 56 | Progressive inability to walk (HP:0002505) | 2.39220762 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.37825751 |
| 58 | Hypsarrhythmia (HP:0002521) | 2.37339464 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.35707440 |
| 60 | Focal dystonia (HP:0004373) | 2.35434737 |
| 61 | Hemiplegia (HP:0002301) | 2.33869047 |
| 62 | Mutism (HP:0002300) | 2.31278045 |
| 63 | Intention tremor (HP:0002080) | 2.30189484 |
| 64 | Peripheral hypomyelination (HP:0007182) | 2.28333231 |
| 65 | Status epilepticus (HP:0002133) | 2.28191036 |
| 66 | Inability to walk (HP:0002540) | 2.24310104 |
| 67 | Bradykinesia (HP:0002067) | 2.23404979 |
| 68 | Apathy (HP:0000741) | 2.18219619 |
| 69 | Insomnia (HP:0100785) | 2.13359795 |
| 70 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.11965778 |
| 71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.11965778 |
| 72 | Resting tremor (HP:0002322) | 2.10514163 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.07600134 |
| 74 | Diplopia (HP:0000651) | 2.06063720 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.06063720 |
| 76 | Heterochromia iridis (HP:0001100) | 2.03328453 |
| 77 | Abnormality of the corticospinal tract (HP:0002492) | 2.03011649 |
| 78 | Agitation (HP:0000713) | 2.01861035 |
| 79 | Generalized myoclonic seizures (HP:0002123) | 2.00344043 |
| 80 | Incomplete penetrance (HP:0003829) | 1.98739814 |
| 81 | Mild short stature (HP:0003502) | 1.98580808 |
| 82 | Diminished motivation (HP:0000745) | 1.97114409 |
| 83 | Gait ataxia (HP:0002066) | 1.96657114 |
| 84 | Obstructive sleep apnea (HP:0002870) | 1.95628505 |
| 85 | Megalencephaly (HP:0001355) | 1.95081558 |
| 86 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92852172 |
| 87 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92852172 |
| 88 | Aplasia involving bones of the extremities (HP:0009825) | 1.92852172 |
| 89 | Bundle branch block (HP:0011710) | 1.92192998 |
| 90 | Lower limb muscle weakness (HP:0007340) | 1.91832164 |
| 91 | Blue irides (HP:0000635) | 1.91743168 |
| 92 | Pointed chin (HP:0000307) | 1.91432260 |
| 93 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91158746 |
| 94 | Sleep apnea (HP:0010535) | 1.90298566 |
| 95 | Pheochromocytoma (HP:0002666) | 1.89692068 |
| 96 | Ocular albinism (HP:0001107) | 1.88983696 |
| 97 | Rapidly progressive (HP:0003678) | 1.84843796 |
| 98 | Lower limb asymmetry (HP:0100559) | 1.84749182 |
| 99 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84665018 |
| 100 | Rigidity (HP:0002063) | 1.84071248 |
| 101 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.83391157 |
| 102 | Iris hypopigmentation (HP:0007730) | 1.81584275 |
| 103 | Diminished movement (HP:0002374) | 1.78671406 |
| 104 | Protruding tongue (HP:0010808) | 1.77539036 |
| 105 | Gait imbalance (HP:0002141) | 1.76695811 |
| 106 | Abnormality of salivation (HP:0100755) | 1.74421796 |
| 107 | Spinal canal stenosis (HP:0003416) | 1.73681399 |
| 108 | Abnormal EKG (HP:0003115) | 1.73479216 |
| 109 | Abnormality of saccadic eye movements (HP:0000570) | 1.73204431 |
| 110 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73192131 |
| 111 | Clonus (HP:0002169) | 1.72400478 |
| 112 | CNS hypomyelination (HP:0003429) | 1.71739473 |
| 113 | Prolonged QT interval (HP:0001657) | 1.71534424 |
| 114 | Polyphagia (HP:0002591) | 1.71518711 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 1.70758072 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.70221457 |
| 117 | Spastic tetraparesis (HP:0001285) | 1.68913956 |
| 118 | Limb dystonia (HP:0002451) | 1.67435859 |
| 119 | Specific learning disability (HP:0001328) | 1.66576463 |
| 120 | Hypoventilation (HP:0002791) | 1.65692787 |
| 121 | Intellectual disability, profound (HP:0002187) | 1.64132734 |
| 122 | Postural tremor (HP:0002174) | 1.63871038 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.63424578 |
| 124 | Deeply set eye (HP:0000490) | 1.63014018 |
| 125 | Delusions (HP:0000746) | 1.62766010 |
| 126 | Syncope (HP:0001279) | 1.62692162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.76295427 |
| 2 | EPHA4 | 4.60608217 |
| 3 | MAP3K9 | 3.85899874 |
| 4 | DAPK2 | 3.09646762 |
| 5 | MAP3K4 | 2.90832072 |
| 6 | CASK | 2.58712616 |
| 7 | MAP2K7 | 2.53720937 |
| 8 | KSR2 | 2.40334319 |
| 9 | MINK1 | 2.27676397 |
| 10 | PAK6 | 2.24560903 |
| 11 | PRKD3 | 2.15041891 |
| 12 | CAMKK1 | 1.99381342 |
| 13 | NTRK2 | 1.91615634 |
| 14 | MAP3K12 | 1.87509696 |
| 15 | MAP2K4 | 1.85735600 |
| 16 | MARK1 | 1.84528755 |
| 17 | NTRK1 | 1.77643434 |
| 18 | RIPK4 | 1.77370431 |
| 19 | CAMKK2 | 1.76702803 |
| 20 | DAPK1 | 1.75301998 |
| 21 | MAP3K2 | 1.68486162 |
| 22 | KSR1 | 1.56380157 |
| 23 | ARAF | 1.51482059 |
| 24 | PLK2 | 1.45439301 |
| 25 | CDK19 | 1.45056049 |
| 26 | CDK5 | 1.44677300 |
| 27 | STK38 | 1.43309354 |
| 28 | GRK5 | 1.40044280 |
| 29 | TAOK1 | 1.37581978 |
| 30 | BMPR2 | 1.35122138 |
| 31 | MAP3K13 | 1.29623261 |
| 32 | LATS2 | 1.27673922 |
| 33 | PRPF4B | 1.25211058 |
| 34 | MAPK13 | 1.22269976 |
| 35 | TNIK | 1.19103355 |
| 36 | SGK223 | 1.07830043 |
| 37 | SGK494 | 1.07830043 |
| 38 | PRKCG | 1.07758561 |
| 39 | TYRO3 | 1.06454155 |
| 40 | CCNB1 | 1.04972250 |
| 41 | SGK2 | 1.04566402 |
| 42 | FES | 0.97104232 |
| 43 | RAF1 | 0.96860035 |
| 44 | CAMK2A | 0.95820323 |
| 45 | LIMK1 | 0.94287979 |
| 46 | RET | 0.94028230 |
| 47 | CAMK1 | 0.93526863 |
| 48 | PNCK | 0.92961648 |
| 49 | SIK2 | 0.92337768 |
| 50 | STK11 | 0.88752216 |
| 51 | PRKCH | 0.82280401 |
| 52 | MAP3K1 | 0.81086381 |
| 53 | PTK2B | 0.80143257 |
| 54 | UHMK1 | 0.79669007 |
| 55 | SGK3 | 0.79645206 |
| 56 | CDK18 | 0.79319394 |
| 57 | MAP3K6 | 0.77661509 |
| 58 | CDK15 | 0.76393850 |
| 59 | OXSR1 | 0.75224562 |
| 60 | TESK1 | 0.74977517 |
| 61 | AKT3 | 0.74857317 |
| 62 | SGK1 | 0.74851244 |
| 63 | CAMK2B | 0.72747028 |
| 64 | CDK14 | 0.70371712 |
| 65 | BRAF | 0.69505987 |
| 66 | PKN1 | 0.69349982 |
| 67 | CDK11A | 0.64755084 |
| 68 | MOS | 0.63598647 |
| 69 | PDGFRA | 0.63139246 |
| 70 | BRSK1 | 0.62830471 |
| 71 | MARK2 | 0.62775325 |
| 72 | PINK1 | 0.61946818 |
| 73 | PAK3 | 0.61305671 |
| 74 | PDK1 | 0.59710102 |
| 75 | PDPK1 | 0.59210941 |
| 76 | ROCK2 | 0.56872942 |
| 77 | MUSK | 0.55954114 |
| 78 | MAP2K1 | 0.55719967 |
| 79 | PTK2 | 0.53426927 |
| 80 | ALK | 0.52516189 |
| 81 | DYRK1A | 0.52221646 |
| 82 | CAMK4 | 0.51860476 |
| 83 | WNK1 | 0.51829264 |
| 84 | MAPK12 | 0.51653536 |
| 85 | CDC42BPA | 0.51087332 |
| 86 | CSNK1G2 | 0.49328880 |
| 87 | RPS6KA3 | 0.49039093 |
| 88 | MET | 0.48978634 |
| 89 | NEK6 | 0.48257872 |
| 90 | PRKCE | 0.47671447 |
| 91 | SIK3 | 0.45304227 |
| 92 | ROCK1 | 0.42819422 |
| 93 | CAMK1G | 0.42322096 |
| 94 | RIPK1 | 0.42227958 |
| 95 | FER | 0.41587266 |
| 96 | MAPK10 | 0.40789238 |
| 97 | PHKG2 | 0.40494374 |
| 98 | PHKG1 | 0.40494374 |
| 99 | LMTK2 | 0.40484483 |
| 100 | CAMK2G | 0.40233466 |
| 101 | SCYL2 | 0.39452053 |
| 102 | CAMK2D | 0.39123580 |
| 103 | FGFR2 | 0.38580581 |
| 104 | CSNK1D | 0.37412749 |
| 105 | DMPK | 0.37055727 |
| 106 | IRAK2 | 0.36191406 |
| 107 | NME1 | 0.35988783 |
| 108 | MAP3K7 | 0.34636229 |
| 109 | DAPK3 | 0.33679564 |
| 110 | PRKCA | 0.33250165 |
| 111 | PRKCZ | 0.31957999 |
| 112 | PAK2 | 0.31925016 |
| 113 | CSNK1A1 | 0.31292873 |
| 114 | RPS6KA2 | 0.31101774 |
| 115 | FYN | 0.30346121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53968097 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.36507841 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80406623 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.72782583 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.71740468 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64651626 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60788154 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57746862 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54366350 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.44431428 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.26208115 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16848415 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.15540635 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05069433 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.95952247 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94364356 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87551680 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.83118526 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.80844416 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.75212568 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.70707750 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.67771814 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64714843 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63474486 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62555096 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59725928 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.58778870 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37528983 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36260525 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.33601761 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33285763 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33199103 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33185051 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31442713 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22573997 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22170452 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.11937017 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11352494 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09168686 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08132981 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05646726 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02637252 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.02144498 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01645079 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01218945 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99069138 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98217377 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.98076635 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93774996 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.90711625 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85353224 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81844875 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76888966 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75737859 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74747314 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73548394 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71221727 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69473336 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69014730 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67368301 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67081812 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66033300 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.65449582 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65286536 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65128770 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61297518 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60830522 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60629753 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59887238 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58004796 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56781029 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56702580 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56653464 |
| 74 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56459768 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54744220 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54229588 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53475242 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52378663 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47965877 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47154321 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45867614 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45169828 |
| 83 | Tight junction_Homo sapiens_hsa04530 | 0.45115579 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43937328 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43257224 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.43254918 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42310070 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42019252 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.41958105 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.41446256 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40905207 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39170506 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38124000 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37174170 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32858390 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31936907 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31678751 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.31488132 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31135108 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31038607 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31031812 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30273228 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29396635 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29070696 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29045267 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.28391078 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27745669 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27546457 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26976536 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23563239 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23467879 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22202205 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21757875 |

